Published in Medical Letter on the CDC and FDA, August 24th, 2003
According to a study from the United States, "Plasma levels of parent compounds and metabolites were determined in adult rhesus monkeys after doses of either 5 mg/kg d-fenfluramine (FEN) or 10 mg/kg d-3,4-methylenedioxymethamphetamine (MDMA) i.m. twice daily for four consecutive days."
"These treatment regimens have been previously shown to produce long-term serotonin (5-HT) depletions," stated John F. Bowyer and collaborators at the Food and Drug Administration, University of Miami, and Glaxo Wellcome. "Peak...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA